172 related articles for article (PubMed ID: 37535809)
21. Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1.
Zhuang Y; Ortega-Ribera M; Thevkar Nagesh P; Joshi R; Huang H; Wang Y; Zivny A; Mehta J; Parikh SM; Szabo G
Hepatology; 2024 Apr; 79(4):752-767. PubMed ID: 37725754
[TBL] [Abstract][Full Text] [Related]
22. Circulating Macrophage Activation Markers Predict Transplant-Free Survival in Patients With Primary Sclerosing Cholangitis.
Bossen L; Vesterhus M; Hov JR; Färkkilä M; Rosenberg WM; Møller HJ; Boberg KM; Karlsen TH; Grønbæk H
Clin Transl Gastroenterol; 2021 Mar; 12(3):e00315. PubMed ID: 33646203
[TBL] [Abstract][Full Text] [Related]
23. Chronic cholestatic liver diseases - Primary biliary cholangitis and Primary sclerosing cholangitis.
Fejfar T; Vaňásek T; Hůlek P
Vnitr Lek; 2020; 66(5):287-300. PubMed ID: 32942866
[TBL] [Abstract][Full Text] [Related]
24. The Role of CCL24 in Primary Sclerosing Cholangitis: Bridging Patient Serum Proteomics to Preclinical Data.
Greenman R; Snir T; Katav A; Aricha R; Mishalian I; Hay O; Frankel M; Lawler J; Saffioti F; Pinzani M; Thorburn D; Peled A; Mor A; Vaknin I
Cells; 2024 Jan; 13(3):. PubMed ID: 38334601
[TBL] [Abstract][Full Text] [Related]
25. Targeting osteopontin to treat primary sclerosing cholangitis.
De Muynck K; Devisscher L
Curr Opin Gastroenterol; 2024 Mar; 40(2):77-84. PubMed ID: 38190383
[TBL] [Abstract][Full Text] [Related]
26. Gut microbiota depletion exacerbates cholestatic liver injury via loss of FXR signalling.
Schneider KM; Candels LS; Hov JR; Myllys M; Hassan R; Schneider CV; Wahlström A; Mohs A; Zühlke S; Liao L; Elfers C; Kilic K; Henricsson M; Molinaro A; Hatting M; Zaza A; Drasdo D; Frissen M; Devlin AS; Gálvez EJC; Strowig T; Karlsen TH; Hengstler JG; Marschall HU; Ghallab A; Trautwein C
Nat Metab; 2021 Sep; 3(9):1228-1241. PubMed ID: 34552267
[TBL] [Abstract][Full Text] [Related]
27. Colitis ameliorates cholestatic liver disease via suppression of bile acid synthesis.
Gui W; Hole MJ; Molinaro A; Edlund K; Jørgensen KK; Su H; Begher-Tibbe B; Gaßler N; Schneider CV; Muthukumarasamy U; Mohs A; Liao L; Jaeger J; Mertens CJ; Bergheim I; Strowig T; Hengstler JG; Hov JR; Marschall HU; Trautwein C; Schneider KM
Nat Commun; 2023 Jun; 14(1):3304. PubMed ID: 37280200
[TBL] [Abstract][Full Text] [Related]
28. Imaging Features of Primary Sclerosing Cholangitis: From Diagnosis to Liver Transplant Follow-up.
Khoshpouri P; Habibabadi RR; Hazhirkarzar B; Ameli S; Ghadimi M; Ghasabeh MA; Menias CO; Kim A; Li Z; Kamel IR
Radiographics; 2019; 39(7):1938-1964. PubMed ID: 31626561
[TBL] [Abstract][Full Text] [Related]
29. Pathological features of primary sclerosing cholangitis identified by bile proteomic analysis.
Rupp C; Bode KA; Leopold Y; Sauer P; Gotthardt DN
Biochim Biophys Acta Mol Basis Dis; 2018 Apr; 1864(4 Pt B):1380-1389. PubMed ID: 28943450
[TBL] [Abstract][Full Text] [Related]
30. Primary sclerosing cholangitis: review for radiologists.
Morgan MA; Khot R; Sundaram KM; Ludwig DR; Nair RT; Mittal PK; Ganeshan DM; Venkatesh SK
Abdom Radiol (NY); 2023 Jan; 48(1):136-150. PubMed ID: 36063181
[TBL] [Abstract][Full Text] [Related]
31. Mast Cell and Innate Immune Cell Communication in Cholestatic Liver Disease.
Bernard JK; Marakovits C; Smith LG; Francis H
Semin Liver Dis; 2023 May; 43(2):226-233. PubMed ID: 37268012
[TBL] [Abstract][Full Text] [Related]
32. CCL24 regulates biliary inflammation and fibrosis in primary sclerosing cholangitis.
Greenman R; Segal-Salto M; Barashi N; Hay O; Katav A; Levi O; Vaknin I; Aricha R; Aharoni S; Snir T; Mishalian I; Olam D; Amer J; Salhab A; Safadi R; Maor Y; Trivedi P; Weston CJ; Saffioti F; Hall A; Pinzani M; Thorburn D; Peled A; Mor A
JCI Insight; 2023 Jun; 8(12):. PubMed ID: 37345655
[TBL] [Abstract][Full Text] [Related]
33. Effect of NGM282, an FGF19 analogue, in primary sclerosing cholangitis: A multicenter, randomized, double-blind, placebo-controlled phase II trial.
Hirschfield GM; Chazouillères O; Drenth JP; Thorburn D; Harrison SA; Landis CS; Mayo MJ; Muir AJ; Trotter JF; Leeming DJ; Karsdal MA; Jaros MJ; Ling L; Kim KH; Rossi SJ; Somaratne RM; DePaoli AM; Beuers U
J Hepatol; 2019 Mar; 70(3):483-493. PubMed ID: 30414864
[TBL] [Abstract][Full Text] [Related]
34. The ascending pathophysiology of cholestatic liver disease.
Jansen PL; Ghallab A; Vartak N; Reif R; Schaap FG; Hampe J; Hengstler JG
Hepatology; 2017 Feb; 65(2):722-738. PubMed ID: 27981592
[TBL] [Abstract][Full Text] [Related]
35. Cholangiocyte-derived exosomal long noncoding RNA H19 promotes cholestatic liver injury in mouse and humans.
Li X; Liu R; Huang Z; Gurley EC; Wang X; Wang J; He H; Yang H; Lai G; Zhang L; Bajaj JS; White M; Pandak WM; Hylemon PB; Zhou H
Hepatology; 2018 Aug; 68(2):599-615. PubMed ID: 29425397
[TBL] [Abstract][Full Text] [Related]
36. Modulation of the Tryptophan Hydroxylase 1/Monoamine Oxidase-A/5-Hydroxytryptamine/5-Hydroxytryptamine Receptor 2A/2B/2C Axis Regulates Biliary Proliferation and Liver Fibrosis During Cholestasis.
Kyritsi K; Chen L; O'Brien A; Francis H; Hein TW; Venter J; Wu N; Ceci L; Zhou T; Zawieja D; Gashev AA; Meng F; Invernizzi P; Fabris L; Wu C; Skill NJ; Saxena R; Liangpunsakul S; Alpini G; Glaser SS
Hepatology; 2020 Mar; 71(3):990-1008. PubMed ID: 31344280
[TBL] [Abstract][Full Text] [Related]
37. Dysfunction of hepatic regulatory T cells in experimental sclerosing cholangitis is related to IL-12 signaling.
Schwinge D; von Haxthausen F; Quaas A; Carambia A; Otto B; Glaser F; Höh B; Thiele N; Schoknecht T; Huber S; Steffens N; Lohse AW; Herkel J; Schramm C
J Hepatol; 2017 Apr; 66(4):798-805. PubMed ID: 27965154
[TBL] [Abstract][Full Text] [Related]
38. The microbiota and the gut-liver axis in primary sclerosing cholangitis.
Hov JR; Karlsen TH
Nat Rev Gastroenterol Hepatol; 2023 Mar; 20(3):135-154. PubMed ID: 36352157
[TBL] [Abstract][Full Text] [Related]
39. Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease.
Shearn CT; Orlicky DJ; Petersen DR
Exp Mol Pathol; 2018 Feb; 104(1):1-8. PubMed ID: 29180269
[TBL] [Abstract][Full Text] [Related]
40. Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis.
Ludwig J; Barham SS; LaRusso NF; Elveback LR; Wiesner RH; McCall JT
Hepatology; 1981; 1(6):632-40. PubMed ID: 7308996
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
